AAAAAA

   
Results: 1-7 |
Results: 7
Successful establishment of long-term bone marrow cultures in 103 patientswith myelodysplastic syndromes
Authors: Alvi, S Shaher, A Shetty, V Henderson, B Dangerfield, B Zorat, F Joshi, L Anthwal, S Lisak, L Little, L Gezer, S Mundle, S Reddy, PL Allampallam, K Huang, XK Galili, N Borok, RZ Raza, A
Citation: S. Alvi et al., Successful establishment of long-term bone marrow cultures in 103 patientswith myelodysplastic syndromes, LEUK RES, 25(11), 2001, pp. 941-954
Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes
Authors: Raza, A Meyer, P Dutt, D Zorat, F Lisak, L Nascimben, F du Randt, M Kaspar, C Goldberg, C Loew, J Dar, S Gezer, S Venugopal, P Zeldis, J
Citation: A. Raza et al., Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes, BLOOD, 98(4), 2001, pp. 958-965
The clinical and biologic significance of abnormal lipid profiles in patients with myelodysplastic syndromes
Authors: Allampallam, K Dutt, D Nair, C Shetty, V Mundle, S Lisak, L Andrews, C Ahmed, B Mazzone, L Zorat, F Borok, R Muzammil, M Gundroo, A Ansaarie, I Raza, A
Citation: K. Allampallam et al., The clinical and biologic significance of abnormal lipid profiles in patients with myelodysplastic syndromes, J HEMATH ST, 9(2), 2000, pp. 247-255
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone
Authors: Raza, A Qawi, H Lisak, L Andric, T Dar, S Andrews, C Venugopal, P Gezer, S Gregory, S Loew, J Robin, E Rifkin, S Hsu, WT Huang, RW
Citation: A. Raza et al., Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone, BLOOD, 95(5), 2000, pp. 1580-1587
Biologic characteristics of 164 patients with myelodysplastic syndromes
Authors: Reza, S Dar, S Andric, T Qawi, H Mundle, S Shetty, V Venugopal, P Ali, I Lisak, L Raza, A
Citation: S. Reza et al., Biologic characteristics of 164 patients with myelodysplastic syndromes, LEUK LYMPH, 33(3-4), 1999, pp. 281-287
Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis
Authors: Dar, S Mundle, S Andric, T Qawi, H Shetty, V Reza, S Mativi, BY Allampallam, K Ali, A Venugopal, P Gezer, S Broady-Robinson, L Cartlidge, J Showel, M Hussaini, S Ragasa, D Ali, I Chaudhry, A Waggoner, S Lisak, L Huang, RW Raza, A
Citation: S. Dar et al., Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis, EUR J HAEMA, 62(2), 1999, pp. 90-94
Biologic characteristics of patients with hypocellular myelodysplastic syndromes
Authors: Goyal, R Qawi, H Ali, I Dar, S Mundle, S Shetty, V Mativi, Y Allampallam, K Lisak, L Loew, J Venugopal, P Gezer, S Robin, E Rifkin, S Raza, A
Citation: R. Goyal et al., Biologic characteristics of patients with hypocellular myelodysplastic syndromes, LEUK RES, 23(4), 1999, pp. 357-364
Risultati: 1-7 |